HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 1175 | 1454 | 80.8% | |
| HF 4 | 2011 | 839 | 1017 | 82.5% | |
| HF 4 | 2012 | 1111 | 1356 | 81.9% | |
| HF 4 | 2013 | 1454 | 1727 | 84.2% | |
| HF004(S) | 2014 | 645 | 725 | 89.0% | |
| HF004(S) | 2015 | 1047 | 1170 | 89.5% | |
| HF004(S) | 2016 | 1386 | 1585 | 87.4% |
